Vanderbilt Vaccine Center

Antibody isolated at VUMC found to halt dengue virus

Using part of an antibody isolated at Vanderbilt that “broadly neutralizes” the human dengue virus, biologists at the University of California San Diego and colleagues have disarmed the mosquito that transmits the disabling and potentially deadly tropical infection.

VUMC-led team isolates antibody that blocks bird flu

VUMC scientists are redoubling their efforts to help people fight off bird flu. Their focus is H7N9, one of the most dangerous of the influenza viruses that have been transmitted from birds to humans.

Early effort to thwart chikungunya infection shows positive results

Phase 1 trial results in new approach to combat the chikungunya

Partnership to help bring Zika virus therapy to clinic

Researchers at Vanderbilt University Medical Center are partnering with the Dutch biopharmaceutical firm Batavia Biosciences and Nashville-based IDBiologics to bring to the clinic a highly potent Zika virus neutralizing antibody they isolated three years ago.

Recipients of the 2019 Dean’s Award for Exceptional Achievement in Graduate Studies are (front row, from left) Margaret Axelrod, Abigail Neininger, Alejandra Romero-Morales, Sheryl Vermudez, Demond Williams, and (back row, from left) James O’Connor, Manuel Castro, Matthew Cottam, Matthew Wleklinski, Michael Doyle and Azadeh Hadadianpour.

Exceptional graduate students honored with Dean’s Award

Eleven graduate students entering their fourth year of training have received the Dean’s Award for Exceptional Achievement in Graduate Studies.

Exceptional graduate students honored with Dean’s Award

Eleven graduate students entering their fourth year of training have received the Dean’s Award for Exceptional Achievement in Graduate Studies.

1 4 5 6 7 8 14